FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376604468> ?p ?o ?g. }

• W4376604468 abstract "Stress-activated kinases are targets of interest in neurodegenerative disease due to their involvement in inflammatory signaling and synaptic dysfunction. The p38α kinase has shown clinical and preclinical promise as a druggable target in several neurodegenerative conditions. We report the radiosynthesis and evaluation of the first positron emission tomography (PET) radiotracer for imaging MAPK p38α/β through radiolabeling of the inhibitor talmapimod (SCIO-469) with carbon-11. [11C]Talmapimod was reliably synthesized by carbon-11 methylation with non-decay corrected radiochemical yields of 3.1 ± 0.7%, molar activities of 38.9 ± 13 GBq/μmol, and >95% radiochemical purity (n = 20). Preclinical PET imaging in rodents revealed a low baseline brain uptake and retention with standardized uptake values (SUV) of ∼0.2 over 90 min; however, pretreatment with the P-glycoprotein (P-gp) drug efflux transporter inhibitor elacridar enabled [11C]talmapimod to pass the blood-brain barrier (>1.0 SUV) with distinct sex differences in washout kinetics. Blocking studies with a structurally dissimilar p38α/β inhibitor, neflamapimod (VX-745), and displacement imaging studies with talmapimod were attempted in elacridar-pretreated rodents, but neither compound displaced radiotracer uptake in the brain of either sex. Ex vivo radiometabolite analysis revealed substantial differences in the composition of radioactive species present in blood plasma but not in brain homogenates at 40 min post radiotracer injection. Digital autoradiography in fresh-frozen rodent brain tissue confirmed that the radiotracer signal was largely non-displaceable in vitro, where self-blocking and blocking with neflamapimod marginally decreased the total signal by 12.9 ± 8.8% and 2.66 ± 2.1% in C57bl/6 healthy controls and 29.3 ± 2.7% and 26.7 ± 12% in Tg2576 rodent brains, respectively. An MDCK-MDR1 assay suggests that talmapimod is likely to suffer from drug efflux in humans as well as rodents. Future efforts should focus on radiolabeling p38 inhibitors from other structural classes to avoid P-gp efflux and non-displaceable binding." @default.
• W4376604468 created "2023-05-17" @default.
• W4376604468 creator A5033482978 @default.
• W4376604468 creator A5069637680 @default.
• W4376604468 date "2023-05-15" @default.
• W4376604468 modified "2023-09-28" @default.
• W4376604468 title "Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [¹¹C]Talmapimod: Effects of Drug Efflux and Sex Differences" @default.
• W4376604468 cites W1516634954 @default.
• W4376604468 cites W1974198922 @default.
• W4376604468 cites W1975974673 @default.
• W4376604468 cites W1983816589 @default.
• W4376604468 cites W1989232881 @default.
• W4376604468 cites W1993961107 @default.
• W4376604468 cites W2016575780 @default.
• W4376604468 cites W2017795530 @default.
• W4376604468 cites W2034502915 @default.
• W4376604468 cites W2046827775 @default.
• W4376604468 cites W2049204919 @default.
• W4376604468 cites W2050690958 @default.
• W4376604468 cites W2055426491 @default.
• W4376604468 cites W2069123208 @default.
• W4376604468 cites W2071645343 @default.
• W4376604468 cites W2072410510 @default.
• W4376604468 cites W2074981365 @default.
• W4376604468 cites W2081858180 @default.
• W4376604468 cites W2088764696 @default.
• W4376604468 cites W2100772783 @default.
• W4376604468 cites W2104290477 @default.
• W4376604468 cites W2110057699 @default.
• W4376604468 cites W2115341926 @default.
• W4376604468 cites W2140508260 @default.
• W4376604468 cites W2149848093 @default.
• W4376604468 cites W2152824905 @default.
• W4376604468 cites W2170192548 @default.
• W4376604468 cites W2193968315 @default.
• W4376604468 cites W2290984097 @default.
• W4376604468 cites W2417575596 @default.
• W4376604468 cites W2558063058 @default.
• W4376604468 cites W2593275615 @default.
• W4376604468 cites W2604807934 @default.
• W4376604468 cites W2613123103 @default.
• W4376604468 cites W2755200731 @default.
• W4376604468 cites W2755384228 @default.
• W4376604468 cites W2778947867 @default.
• W4376604468 cites W2783091149 @default.
• W4376604468 cites W2804716129 @default.
• W4376604468 cites W2808523151 @default.
• W4376604468 cites W2885509648 @default.
• W4376604468 cites W2903061874 @default.
• W4376604468 cites W2938416610 @default.
• W4376604468 cites W2979759717 @default.
• W4376604468 cites W2990953254 @default.
• W4376604468 cites W3010908253 @default.
• W4376604468 cites W3013139410 @default.
• W4376604468 cites W3025943349 @default.
• W4376604468 cites W3047617638 @default.
• W4376604468 cites W3084137976 @default.
• W4376604468 cites W3107395714 @default.
• W4376604468 cites W3122470240 @default.
• W4376604468 cites W3170844892 @default.
• W4376604468 cites W3186740415 @default.
• W4376604468 cites W3203622089 @default.
• W4376604468 cites W4210308805 @default.
• W4376604468 cites W4290793613 @default.
• W4376604468 cites W4321612735 @default.
• W4376604468 cites W4322734560 @default.
• W4376604468 doi "https://doi.org/10.1021/acschemneuro.3c00205" @default.
• W4376604468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37186961" @default.
• W4376604468 hasPublicationYear "2023" @default.
• W4376604468 type Work @default.
• W4376604468 citedByCount "0" @default.
• W4376604468 crossrefType "journal-article" @default.
• W4376604468 hasAuthorship W4376604468A5033482978 @default.
• W4376604468 hasAuthorship W4376604468A5069637680 @default.
• W4376604468 hasConcept C134018914 @default.
• W4376604468 hasConcept C150903083 @default.
• W4376604468 hasConcept C184235292 @default.
• W4376604468 hasConcept C185592680 @default.
• W4376604468 hasConcept C199374082 @default.
• W4376604468 hasConcept C207001950 @default.
• W4376604468 hasConcept C2775842073 @default.
• W4376604468 hasConcept C2776970183 @default.
• W4376604468 hasConcept C2778402981 @default.
• W4376604468 hasConcept C2989005 @default.
• W4376604468 hasConcept C51551487 @default.
• W4376604468 hasConcept C529278444 @default.
• W4376604468 hasConcept C55493867 @default.
• W4376604468 hasConcept C57074206 @default.
• W4376604468 hasConcept C71924100 @default.
• W4376604468 hasConcept C86803240 @default.
• W4376604468 hasConcept C98274493 @default.
• W4376604468 hasConceptScore W4376604468C134018914 @default.
• W4376604468 hasConceptScore W4376604468C150903083 @default.
• W4376604468 hasConceptScore W4376604468C184235292 @default.
• W4376604468 hasConceptScore W4376604468C185592680 @default.
• W4376604468 hasConceptScore W4376604468C199374082 @default.
• W4376604468 hasConceptScore W4376604468C207001950 @default.
• W4376604468 hasConceptScore W4376604468C2775842073 @default.
• W4376604468 hasConceptScore W4376604468C2776970183 @default.
• W4376604468 hasConceptScore W4376604468C2778402981 @default.

• next